Erwin Schultz

4.4k total citations
60 papers, 2.2k citations indexed

About

Erwin Schultz is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Erwin Schultz has authored 60 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 18 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Erwin Schultz's work include Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (12 papers) and vaccines and immunoinformatics approaches (10 papers). Erwin Schultz is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), T-cell and B-cell Immunology (12 papers) and vaccines and immunoinformatics approaches (10 papers). Erwin Schultz collaborates with scholars based in Germany, United States and Belgium. Erwin Schultz's co-authors include Gerold Schuler, Thomas Berger, Pierre van der Bruggen, Thierry Boon, Pascal Chaux, Beatrice Schuler‐Thurner, Vincent Stroobant, Benoı̂t J. Van den Eynde, Jacques Chapiro and Georg Weinlich and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Erwin Schultz

58 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erwin Schultz Germany 21 1.5k 871 756 203 130 60 2.2k
Detlef Dieckmann Germany 14 3.1k 2.1× 1.0k 1.2× 985 1.3× 165 0.8× 152 1.2× 22 3.6k
Marat Alimzhanov United States 18 1.7k 1.1× 656 0.8× 465 0.6× 246 1.2× 89 0.7× 41 2.4k
Yasumichi Hitoshi Japan 22 1.1k 0.7× 814 0.9× 421 0.6× 127 0.6× 139 1.1× 48 2.1k
Shinsuke Taki Japan 28 2.7k 1.8× 800 0.9× 916 1.2× 89 0.4× 149 1.1× 64 3.5k
Stephen J. Ullrich United States 18 848 0.6× 1.1k 1.2× 727 1.0× 93 0.5× 122 0.9× 25 2.2k
Dennis M. Willerford United States 21 1.8k 1.2× 842 1.0× 609 0.8× 121 0.6× 69 0.5× 28 2.8k
Maria Ferrantini Italy 27 1.7k 1.1× 768 0.9× 902 1.2× 73 0.4× 91 0.7× 47 2.5k
Ekambar R. Kandimalla United States 36 1.6k 1.1× 1.8k 2.0× 476 0.6× 76 0.4× 70 0.5× 109 3.3k
Andrew L. Snow United States 28 1.4k 0.9× 747 0.9× 901 1.2× 238 1.2× 58 0.4× 63 2.5k
Yuji Wano Japan 21 1.7k 1.1× 442 0.5× 290 0.4× 160 0.8× 67 0.5× 55 2.4k

Countries citing papers authored by Erwin Schultz

Since Specialization
Citations

This map shows the geographic impact of Erwin Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin Schultz more than expected).

Fields of papers citing papers by Erwin Schultz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erwin Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin Schultz. The network helps show where Erwin Schultz may publish in the future.

Co-authorship network of co-authors of Erwin Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Erwin Schultz. A scholar is included among the top collaborators of Erwin Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin Schultz. Erwin Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walter, Lauren A., et al.. (2024). Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients. American Journal of Clinical Dermatology. 26(1). 139–146. 1 indexed citations
2.
Schultz, Erwin, et al.. (2023). Das kutane Plattenepithelkarzinom – ein Update. Laryngo-Rhino-Otologie. 102(10). 735–741. 1 indexed citations
3.
Stoevesandt, Johanna, Axel J. Hueber, Ulrike Hüffmeier, et al.. (2023). VEXAS‐Syndrome, a newly described autoinflammatory systemic disease with dermatologic manifestations. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 21(12). 1456–1463. 5 indexed citations
4.
Schultz, Erwin, et al.. (2019). Das maligne Melanom. MMW - Fortschritte der Medizin. 161(10). 42–50. 2 indexed citations
5.
Kakkassery, Vinodh, et al.. (2018). Das fortgeschrittene periokuläre Basalzellkarzinom – eine therapeutische Herausforderung. Der Ophthalmologe. 116(3). 273–277. 6 indexed citations
6.
Debus, Dirk, et al.. (2016). Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient. Lung Cancer. 95. 35–38. 32 indexed citations
7.
Schultz, Erwin, et al.. (2015). Kutane Diphtherie nach Bagatellverletzung in Sri Lanka. Der Hautarzt. 67(2). 169–172. 2 indexed citations
8.
Schultz, Erwin & Gerold Schuler. (2008). Impfstrategien zur Behandlung des Melanoms. Der Hautarzt. 59(10). 785–792. 1 indexed citations
9.
Reichle, Albrecht, Thomas Vogt, Brigitte Coras, et al.. (2007). Targeted combined anti-inflammatory and angiostatic therapy in advanced melanoma: a randomized phase II trial. Melanoma Research. 17(6). 360–364. 33 indexed citations
10.
Schaft, Niels, Jan Dörrie, Verena Beck, et al.. (2005). Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. The Journal of Immunology. 174(9). 5884–5884. 3 indexed citations
11.
Schaft, Niels, Jan Dörrie, Verena Beck, et al.. (2005). Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation. The Journal of Immunology. 174(5). 3087–3097. 115 indexed citations
12.
Veldman, Christian, Wolfgang Uter, Ralf Waßmuth, et al.. (2004). T Cell Recognition of Desmoglein 3 Peptides in Patients with Pemphigus Vulgaris and Healthy Individuals. The Journal of Immunology. 172(6). 3883–3892. 93 indexed citations
13.
Schultz, Erwin, Beatrice Schuler‐Thurner, Vincent Stroobant, et al.. (2004). Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy. The Journal of Immunology. 172(2). 1304–1310. 54 indexed citations
14.
Humrich, Jens Y., et al.. (2003). Antigen loading of dendritic cells with whole tumor cell preparations. Journal of Immunological Methods. 277(1-2). 1–16. 62 indexed citations
15.
Schuler‐Thurner, Beatrice, Erwin Schultz, Thomas Berger, et al.. (2002). Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells. The Journal of Experimental Medicine. 195(10). 1279–1288. 391 indexed citations
16.
Schultz, Erwin, Dieter Kaufmann, Sigrid Tinschert, et al.. (2002). Segmental Neurofibromatosis. Dermatology. 204(4). 296–297. 14 indexed citations
17.
Bruggen, Pierre van der, Yi Zhang, Pascal Chaux, et al.. (2002). Tumor‐specific shared antigenic peptides recognized by human T cells. Immunological Reviews. 188(1). 51–64. 311 indexed citations
18.
Bilsborough, Janine, Christophe Panichelli, Guy Warnier, et al.. (2002). A MAGE‐3 peptide presented by HLA‐B44 is also recognized by cytolytic T lymphocytes on HLA‐B18. Tissue Antigens. 60(1). 16–24. 11 indexed citations
19.
Schultz, Erwin, Thomas L. Diepgen, Peter Von Den Driesch, & O. P. Hornstein. (1995). Systemic corticosteroids are important in the treatment of Fournier's gangrene: a case report. British Journal of Dermatology. 133(4). 633–635. 14 indexed citations
20.
Schultz, Erwin, Reinhard Dummer, Jürgen C. Becker, Detlef Zillikens, & Günter Burg. (1994). Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro. Archives of Dermatological Research. 286(2). 73–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Detlef Dieckmann Breakdown of academic impact, for papers by Marat Alimzhanov Breakdown of academic impact, for papers by Yasumichi Hitoshi Breakdown of academic impact, for papers by Shinsuke Taki Breakdown of academic impact, for papers by Stephen J. Ullrich Breakdown of academic impact, for papers by Dennis M. Willerford Breakdown of academic impact, for papers by Maria Ferrantini Breakdown of academic impact, for papers by Ekambar R. Kandimalla Breakdown of academic impact, for papers by Andrew L. Snow Breakdown of academic impact, for papers by Yuji Wano
Rankless by CCL
2026